Subscribe for great stories in your community!
Currently there is no U.S. Food and Drug Administration-approved medicine for nonalcoholic steatohepatitis, also referred to as NASH.
NASH is a fatty liver…
A group of companies including King of Prussia-based CSL Behring are currently testing an experimental treatment for COVID-19 derived from the convalescent plasma…
Before we send you to this site, please subscribe to our daily newsletter.
